Increasing access to nonprescription medicines: A global public health challenge and opportunity

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 3, 2010, Pages 267-269

  Hemwall, E L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PANTOPRAZOLE; TETRAHYDROLIPSTATIN;

ALLERGY; COMMON COLD; COUGHING; DRUG APPROVAL; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH SERVICE; HEARTBURN; LIFESTYLE MODIFICATION; PAIN; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; SELF CARE; SHORT SURVEY; SMOKING CESSATION; WEIGHT REDUCTION;

HUMANS; NONPRESCRIPTION DRUGS; PUBLIC HEALTH; SELF MEDICATION; WORLD HEALTH;

EID: 77149163313     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.279     Document Type: Short Survey

References (5)

1. US Government Accountability Office. Nonprescription Drugs: Considerations Regarding a Behind-the-Counter Drug Class (February 2009).
2. Shiffman, S. & Sweeney, C.T. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability? Health Policy 86, 17-26 (2008).
3. Fuster, V. Lipid lowering: education is key. Nat. Rev. Cardiol. 6, 609-610 (2009).
4. Melin, J. et al. A Consumer Use Study of Over-the-Counter Lovastatin (CUSTOM). Am. J. Cardiol. 94, 1243-1248 (2004).
5. Cannon, C. Can the polypill save the world from heart disease? Lancet 373, 1313-1314 (2009).